The SpectaCell™ platform captures dynamic cell behavior, for a faster, deeper, and simpler path to advance CAR-T and other therapies.
Advantages
One platform
from discovery to release
Breaking through the analytical silo’s within the development funnel
Advantages
One platform from discovery to release
Breaking through the analytical silo’s within the development funnel
Problem
Current potency testing slows
access to cell therapy
New cancer treatments hold great promise, yet progress is slow and approvals stall because data are trapped in silo’s along the drug development.


Lead ID & process development
Clinical manufacturing QC
Understand the mode of action
Speed up lead ID
Fine tune product & process
Get robust, deep data
Stackable, single sample QC
Release the same day
Cell dynamics based potency
No labels, no prep
Technology
Providing one tool to accelerate cell therapies
SpectaCell's unique platform enables robust, fast characterization of cell therapies throughout R&D and clinical manufacturing stages. It's one platform for all, allowing researchers, developers and manufacturers to better predict potency of therapies, improving efficiency and time to market.








The next-gen potency test for cell therapies
Redefining potency testing through behavior cytomics



Lens-free imaging & AI analytics tracks morphological & kinetic changes at single cell resolution
The micro-compartimentalized cartridge pairs effector and target cells to capture thousands of killing events
The hybrid data engine provides secure analytics for deeper insight & audit trail




Technology built on
decades of expertise
We combine a decade of advances in nano- and digital technologies with cell biology to solve analytical bottlenecks in drug development and manufacturing.

Backed by



